Key Details
Price
$1.57Annual ROE
-215.13%Beta
0.63Events Calendar
Next earnings date:
Feb 13, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Sep 25, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Nov 19, 24 Benchmark
Speculative BuyOct 1, 24 Benchmark
Speculative BuyOct 3, 23 Benchmark
Speculative BuySep 25, 23 HC Wainwright & Co.
BuySep 21, 23 Maxim Group
BuySep 18, 23 HC Wainwright & Co.
BuyMay 18, 23 Benchmark
Speculative BuyFeb 14, 23 Benchmark
Speculative BuyJul 27, 22 Ladenburg Thalmann
BuyMay 25, 21 Benchmark
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Anebulo Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?
ANEB
Zacks Investment ResearchOctober 19, 2023
Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Conmed (CNMD) have performed compared to their sector so far this year.
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001
ANEB
Zacks Investment ResearchAugust 22, 2023
Anebulo (ANEB) gains on positive FDA response for the phase III development of its lead candidate ANEB-001 for treating patients with acute cannabinoid intoxication.
Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?
ANEB
Zacks Investment ResearchJune 12, 2023
Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Aquestive Therapeutics (AQST) have performed compared to their sector so far this year.
Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year?
ANEB
Zacks Investment ResearchMay 24, 2023
Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Ligand Pharmaceuticals (LGND) have performed compared to their sector so far this year.
FAQ
- What is the ticker symbol for Anebulo Pharmaceuticals?
- Does Anebulo Pharmaceuticals pay dividends?
- What sector is Anebulo Pharmaceuticals in?
- What industry is Anebulo Pharmaceuticals in?
- What country is Anebulo Pharmaceuticals based in?
- When did Anebulo Pharmaceuticals go public?
- Is Anebulo Pharmaceuticals in the S&P 500?
- Is Anebulo Pharmaceuticals in the NASDAQ 100?
- Is Anebulo Pharmaceuticals in the Dow Jones?
- When was Anebulo Pharmaceuticals's last earnings report?
- When does Anebulo Pharmaceuticals report earnings?
- Should I buy Anebulo Pharmaceuticals stock now?
What is the ticker symbol for Anebulo Pharmaceuticals?
The ticker symbol for Anebulo Pharmaceuticals is NASDAQ:ANEB
Does Anebulo Pharmaceuticals pay dividends?
No, Anebulo Pharmaceuticals does not pay dividends
What sector is Anebulo Pharmaceuticals in?
Anebulo Pharmaceuticals is in the Healthcare sector
What industry is Anebulo Pharmaceuticals in?
Anebulo Pharmaceuticals is in the Biotechnology industry
What country is Anebulo Pharmaceuticals based in?
Anebulo Pharmaceuticals is headquartered in United States
When did Anebulo Pharmaceuticals go public?
Anebulo Pharmaceuticals's initial public offering (IPO) was on May 7, 2021
Is Anebulo Pharmaceuticals in the S&P 500?
No, Anebulo Pharmaceuticals is not included in the S&P 500 index
Is Anebulo Pharmaceuticals in the NASDAQ 100?
No, Anebulo Pharmaceuticals is not included in the NASDAQ 100 index
Is Anebulo Pharmaceuticals in the Dow Jones?
No, Anebulo Pharmaceuticals is not included in the Dow Jones index
When was Anebulo Pharmaceuticals's last earnings report?
Anebulo Pharmaceuticals's most recent earnings report was on Nov 13, 2024
When does Anebulo Pharmaceuticals report earnings?
The next expected earnings date for Anebulo Pharmaceuticals is Feb 13, 2025
Should I buy Anebulo Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions